You are here: Home » Current Affairs » Coronavirus » News
Business Standard

No provision of insurance for recipients of Covid-19 vaccine: Choubey

There is no provision of insurance for recipients of COVID-19 vaccine against any kind of side effects or medical complications that may arise due to the inoculation

Coronavirus | Coronavirus Vaccine | Coronavirus Tests

Press Trust of India  |  New Delhi 

Jabalpur: A medic administers the first dose of Covishield vaccine to a frontline worker, after the launch of Covid-19 vaccination drive at Victoria Hospital in Jabalpur, Jan. 16, 2021. (PTI Photo)
Coronavirus vaccination | File photo

There is no provision of insurance for recipients of COVID-19 vaccine against any kind of side effects or medical complications that may arise due to the inoculation, Rajya Sabha was informed on Tuesday.

The COVID-19 vaccination is entirely voluntary for the beneficiary, Minister of State for Health Ashwini Choubey said in response to a question onwhether those administered/to be administered with the COVID-19 vaccines are insured against any kind of side effects or medical complications that may arise due to inoculation.

Measures have been put in place like availability of anaphylaxis kits at each vaccination site, immediate referral to AEFI management centre and observation of vaccine recipients for 30 minutes at session site for any adverse events so as to ensure timely corrective measure, Choubey said in a written reply.

"Also the AEFI management of such cases are provided free of cost treatment in Public Health Facilities," he said.

On Adverse Effects Following Immunisation (AEFI) arising from the use of Covaxin and Covishield, Choubey saidtill February 4, a total of 81 Adverse Event Following Immunisation (AEFIs) i.e. 0.096 per cent AEFIs cases have been reported out of total beneficiaries vaccinated with Covaxin vaccine.

For Covishield vaccine, a total of 8,402 AEFIs, i.e. 0.192 per cent AEFI cases have been reported out of total beneficiaries vaccinated, Choubey said in an another reply.

Most of these are minor AEFIs like anxiety, vertigo, giddiness, dizziness, fever, pain, rashes, and headache which are self-limiting and all people have recovered.

Adverse Event Following Immunization (AEFI) of COVID-19 vaccines are monitored through a well-structured and robust AEFI surveillance system.

The surveillance system includes district, state and national level AEFI committees, he said.

The COVID-19 Vaccines Operational Guidelines on planning and implementation of vaccination roll-out have been shared with all states/UTs.

COVID-19 vaccination of healthcare workers and frontline workers is ongoing and the vaccination coverage along with AEFIs are being monitored regularly at block, district, state and national level.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Tue, February 09 2021. 14:59 IST